Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro

BACKGROUND: Up-regulation of PIK3R3 (Phosphoinositide-3-Kinase Regulatory Subunit 3), the regulatory subunit of PI3K is correlated with the drug resistance of the glioblastoma cells. In the present study, the effect of PIK3R3 siRNA on erlotinib sensitivity of the U373-MG glioblastoma cells was explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini, Razieh, Karami, Hadi, Bayat, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080388/
https://www.ncbi.nlm.nih.gov/pubmed/34967581
http://dx.doi.org/10.31557/APJCP.2021.22.12.3993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080388/
https://www.ncbi.nlm.nih.gov/pubmed/34967581
http://dx.doi.org/10.31557/APJCP.2021.22.12.3993

Ejemplares similares